Antihypertensive treatment: cardiovascular risks and monotherapy.
D000959:Antihypertensive Agents / Q000627:therapeutic use*; D001581:Benzothiadiazines; D002318:Cardiovascular Diseases / Q000517:prevention & control*; D002561:Cerebrovascular Disorders / Q000517:prevention & control; D004232:Diuretics; D006143:Guanabenz / Q000627:therapeutic use; D006801:Humans; D011433:Propranolol / Q000627:therapeutic use; D012306:Risk; D049993:Sodium Chloride Symporter Inhibitors / Q000627:therapeutic use
D000959:Antihypertensive Agents; D001581:Benzothiadiazines; D004232:Diuretics; D049993:Sodium Chloride Symporter Inhibitors; D011433:Propranolol; D006143:Guanabenz